Imel EA - Search Results

1

Prolonged Correction of Serum Phosphorus in Adults With X-Linked Hypophosphatemia Using Monthly Doses of KRN23.

Imel EA, Zhang X, Ruppe MD, Weber TJ, Klausner MA, Ito T, Vergeire M, Humphrey JS, Glorieux FH, Portale AA, Insogna K, Peacock M, Carpenter TO. Imel EA, et al. J Clin Endocrinol Metab. 2015 Jul;100(7):2565-73. doi: 10.1210/jc.2015-1551. Epub 2015 Apr 28. J Clin Endocrinol Metab. 2015. PMID: 25919461 Free PMC article. Clinical Trial.

2

Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia.

Imel EA, Peacock M, Pitukcheewanont P, Heller HJ, Ward LM, Shulman D, Kassem M, Rackoff P, Zimering M, Dalkin A, Drobny E, Colussi G, Shaker JL, Hoogendoorn EH, Hui SL, Econs MJ. Imel EA, et al. J Clin Endocrinol Metab. 2006 Jun;91(6):2055-61. doi: 10.1210/jc.2005-2105. Epub 2006 Mar 21. J Clin Endocrinol Metab. 2006. PMID: 16551733 Free article.

3

Intronic deletions in the SLC34A3 gene cause hereditary hypophosphatemic rickets with hypercalciuria.

Ichikawa S, Sorenson AH, Imel EA, Friedman NE, Gertner JM, Econs MJ. Ichikawa S, et al. Among authors: imel ea. J Clin Endocrinol Metab. 2006 Oct;91(10):4022-7. doi: 10.1210/jc.2005-2840. Epub 2006 Jul 18. J Clin Endocrinol Metab. 2006. PMID: 16849419

4

Tumoral calcinosis presenting with eyelid calcifications due to novel missense mutations in the glycosyl transferase domain of the GALNT3 gene.

Ichikawa S, Imel EA, Sorenson AH, Severe R, Knudson P, Harris GJ, Shaker JL, Econs MJ. Ichikawa S, et al. Among authors: imel ea. J Clin Endocrinol Metab. 2006 Nov;91(11):4472-5. doi: 10.1210/jc.2006-1247. Epub 2006 Aug 29. J Clin Endocrinol Metab. 2006. PMID: 16940445

5

FGF23 concentrations vary with disease status in autosomal dominant hypophosphatemic rickets.

Imel EA, Hui SL, Econs MJ. Imel EA, et al. J Bone Miner Res. 2007 Apr;22(4):520-6. doi: 10.1359/jbmr.070107. J Bone Miner Res. 2007. PMID: 17227222 Free article.

6

Novel GALNT3 mutations causing hyperostosis-hyperphosphatemia syndrome result in low intact fibroblast growth factor 23 concentrations.

Ichikawa S, Guigonis V, Imel EA, Courouble M, Heissat S, Henley JD, Sorenson AH, Petit B, Lienhardt A, Econs MJ. Ichikawa S, et al. Among authors: imel ea. J Clin Endocrinol Metab. 2007 May;92(5):1943-7. doi: 10.1210/jc.2006-1825. Epub 2007 Feb 20. J Clin Endocrinol Metab. 2007. PMID: 17311862

7

Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations.

Imel EA, DiMeglio LA, Hui SL, Carpenter TO, Econs MJ. Imel EA, et al. J Clin Endocrinol Metab. 2010 Apr;95(4):1846-50. doi: 10.1210/jc.2009-1671. Epub 2010 Feb 15. J Clin Endocrinol Metab. 2010. PMID: 20157195 Free PMC article. Clinical Trial.

8

A clinician's guide to X-linked hypophosphatemia.

Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL. Carpenter TO, et al. Among authors: imel ea. J Bone Miner Res. 2011 Jul;26(7):1381-8. doi: 10.1002/jbmr.340. Epub 2011 May 2. J Bone Miner Res. 2011. PMID: 21538511 Free PMC article. Review.

9

Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans.

Imel EA, Peacock M, Gray AK, Padgett LR, Hui SL, Econs MJ. Imel EA, et al. J Clin Endocrinol Metab. 2011 Nov;96(11):3541-9. doi: 10.1210/jc.2011-1239. Epub 2011 Aug 31. J Clin Endocrinol Metab. 2011. PMID: 21880793 Free PMC article.

10

Approach to the hypophosphatemic patient.

Imel EA, Econs MJ. Imel EA, et al. J Clin Endocrinol Metab. 2012 Mar;97(3):696-706. doi: 10.1210/jc.2011-1319. J Clin Endocrinol Metab. 2012. PMID: 22392950 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

88 results

Search Page